Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 5000.00 | 2808.68 | 5064.00 | 7795.00 | 0.6497 | 0.4922 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 8228.00 | 7795.00 | 1.0555 | 1.0748 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 7909.00 | 7795.00 | 1.0146 | 1.0198 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 8030.00 | 7795.00 | 1.0301 | 1.0407 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 4180.00 | 7795.00 | 0.5362 | 0.3100 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 8184.00 | 7795.00 | 1.0499 | 1.0672 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 7727.00 | 7795.00 | 0.9913 | 0.9881 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 8059.00 | 7795.00 | 1.0339 | 1.0457 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 5000.00 | 2808.68 | 8051.00 | 7795.00 | 1.0328 | 1.0444 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7479.00 | 7795.00 | 0.9595 | 0.9446 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 7817.00 | 7795.00 | 1.0028 | 1.0038 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 8108.00 | 7795.00 | 1.0402 | 1.0542 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 5000.00 | 2808.68 | 2749.00 | 7795.00 | 0.3527 | -0.0145 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 8112.00 | 7795.00 | 1.0407 | 1.0549 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 7294.00 | 7795.00 | 0.9357 | 0.9118 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 7994.00 | 7795.00 | 1.0255 | 1.0345 |
| BT-20 | Lapatinib | 1 | uM | 9 | 5000.00 | 2808.68 | 7855.00 | 7795.00 | 1.0077 | 1.0104 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7790.00 | 7795.00 | 0.9994 | 0.9991 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 111.00 | 118.00 | 0.9407 | 0.8395 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 156.25 | 71.09 | 143.00 | 118.00 | 1.2119 | 1.6013 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 156.25 | 71.09 | 132.00 | 118.00 | 1.1186 | 1.3315 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 179.00 | 118.00 | 1.5169 | 2.5365 |
| BT-20 | Erlotinib | 1 | uM | 9 | 156.25 | 71.09 | 145.00 | 118.00 | 1.2288 | 1.6512 |
| BT-20 | Lapatinib | 10 | uM | 9 | 156.25 | 71.09 | 75.00 | 118.00 | 0.6356 | 0.0760 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 166.00 | 118.00 | 1.4068 | 2.1900 |